The 11th annual
Amsterdam Immunogenicity & Tolerance Seminar
November 7, 2025 | 9:30 am – 5:00 pm | The Hilton Apollolaan Hotel
About the Amsterdam Immunogenicity & Tolerance Seminar:
Now in its 11th year, The Amsterdam Immunogenicity & Tolerance Seminar will showcase talks from expert biologics and vaccine developers from industry and academia highlighting how immunogenicity and tolerance have played a role in their recent work.
Previous year’s speakers included visionaries from Leiden University Medical Centre, Pfizer, Inc., Utrecht University, EpiVax, Inc., and more. Topics cover updates on the preclinical and clinical development of tolerance-inducing therapies for autoimmune diseases, immunogenicity assessment strategies and case studies for selection of optimal biologics and vaccines, and updates on how to address hyporesponsiveness and off-target effects of vaccines.
In addition to the talks, there will be networking opportunities, poster presentations, and more.
As a leader in the field of preclinical immunogenicity assessment, design, and optimization of biologics and vaccines, in addition to a developer of a tolerance-inducing therapy, EpiVax hosts this seminar to connect with Europe-based collaborators and to bring industry and academic experts together to share new ideas and present research updates in the space.
Please note: This is an in-person event with no options for virtual attendance.
Check out past year’s AIT Seminars:
2024 Amsterdam Immunogenicity & Tolerance Seminar
2023 Amsterdam Immunogenicity & Tolerance Seminar
2021 Amsterdam Immunogenicity & Tolerance Seminar
More information about the Amsterdam Immunogenicity & Tolerance Seminar will be released soon, sign up now to save the date and be the first to receive updates!
